Kyobo 8 Special Purpose Acquisition Company (307280) - Total Liabilities
Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has total liabilities worth ₩7.69 Billion KRW (≈ $5.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Kyobo 8 Special Purpose Acquisition Comp (307280) equity growth momentum to track the company's year-over-year net asset growth rate.
Kyobo 8 Special Purpose Acquisition Company - Total Liabilities Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's total liabilities have evolved over time, based on quarterly financial data. See Kyobo 8 Special Purpose Acquisition Comp free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Kyobo 8 Special Purpose Acquisition Company Competitors by Total Liabilities
The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Renta Corporacion Real Estate SA
MC:REN
|
Spain | €9.31 Million |
|
Eupe Corporation Bhd
KLSE:6815
|
Malaysia | RM374.69 Million |
|
Perdana Gapura Prima Tbk
JK:GPRA
|
Indonesia | Rp534.55 Billion |
|
Econframe Bhd
KLSE:0227
|
Malaysia | RM70.29 Million |
|
A2Z Infra Engineering Limited
NSE:A2ZINFRA
|
India | Rs4.58 Billion |
|
Reservoir Link Energy Bhd
KLSE:0219
|
Malaysia | RM94.16 Million |
|
Environmental Group Ltd (the)
AU:EGL
|
Australia | AU$45.24 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Kyobo 8 Special Purpose Acquisition Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Kyobo 8 Special Purpose Acquisition Comp.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kyobo 8 Special Purpose Acquisition Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual total liabilities of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩5.00 Billion ≈ $3.39 Million |
+24.99% |
| 2024-12-31 | ₩4.00 Billion ≈ $2.71 Million |
-61.07% |
| 2023-12-31 | ₩10.28 Billion ≈ $6.97 Million |
-15.10% |
| 2022-12-31 | ₩12.11 Billion ≈ $8.20 Million |
-- |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more